With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Although research has demonstrated the effectiveness of ICDs in preventing sudden cardiac death, many eligible patients still do not receive them. Join Drs. Prystowsky, Califf, Al-Khatib, Yancy, and Daniel in a lively discussion on how to eliminate these disparities.
Recent data among heart patients have suggested that approximately 2.3% of patients with a defected implant lead attached to their defibrillator will experience lead fracture within 30 months of having the device implanted. What are your thoughts and is this happening in your clinical practice?
Sudden cardiac death (SCD) affects all age groups and can occur in any setting. While rare, sudden death among young adults is a devastating occurrence, diagnostic evaluation using echocardiography and ECGs as screening instruments in addition to a thorough history and physical examination may help identify young individuals at risk for SCD. Click to take the survey and compare answers. The results will help us create future CME programming.
The world's first MR-conditional pacemaker system designed for safe use in MRI represents a major milestone in the evolution of ICDs. Dr. Bruce Wilkoff from the Cleveland Clinic speaks on the significance of having this new technology available to patients.
Join Drs. Prystowsky, Lau, and Oseroff as they provide an international perspective on the prevention of sudden cardiac arrest in the Pacific Rim and South America.
More than 22 million people worldwide suffer from heart failure (HF), with most HF hospitalizations caused by excessive fluid accumulation in the chest cavity. Implantable cardioverter defibrillators (ICDs) have been shown to reduce symptoms and improve exercise capacity in people with HF. Click to take the survey and compare answers. The results will help us create future CME programming.
Identifying appropriate patients for cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillators (ICDs) is crucial for the prevention of sudden cardiac arrest as well as for cardiac resynchronization.
Can genetic screening identify patients at increased risk for these cardiac events if left untreated? Join Dr Priori for a review of the current data on this rapidly evolving topic.
Data have shown that less than 40% of eligible patients hospitalized for heart failure received ICDs. Rates of use among women and black patients were significantly lower than among white men. Join Drs Fonarow, Hernandez, and Peterson in a lively discussion in how to overcome these disparities.
Acknowledgements
CME provider: Medscape, LLC.
The Sudden Cardiac Arrest clinical theme is supported by an independent educational grant from Medtronic, Inc.